The global patient monitoring and ultrasound devices display market size accounted for USD 5.98 billion in 2024 and is predicted to increase from USD 6.33 billion in 2025 to approximately USD 10.65 billion by 2034, expanding at a CAGR of 5.95% from 2025 to 2034. The rising demand for advanced imaging technologies and real-time data is boosting the growth of the market. Moreover, advancements in display technology support market expansion.
The north america marine biotechnology market size accounted for USD 2.98 billion in 2024 and is predicted to increase from USD 3.20 billion in 2025 to approximately USD 6.05 billion by 2034, expanding at a CAGR of 7.34% from 2025 to 2034. The market growth is attributed to increasing investments in sustainable marine-derived products for pharmaceuticals, nutraceuticals, and industrial applications across North America.
The global diagnostic dermatology equipment market size accounted for USD 13.14 billion in 2024 and is predicted to increase from USD 14.82 billion in 2025 to approximately USD 44 billion by 2034, expanding at a CAGR of 12.85% from 2025 to 2034. The growth of the diagnostic dermatology equipment market is driven by the rising cases of skin cancer, increasing awareness of early diagnostics, and advancements in imaging technologies.
The global duchenne muscular dystrophy drugs market size accounted for USD 4.1 billion in 2024 and is predicted to increase from USD 4.79 billion in 2025 to approximately USD 19.46 billion by 2034, expanding at a CAGR of 16.85% from 2025 to 2034. The Duchenne muscular dystrophy drugs market is growing due to advancements in genetic therapies, rising global demand for effective treatments, and a strong pipeline of emerging drugs.
The global technetium-99m market size accounted for USD 7.15 billion in 2024 and is predicted to increase from USD 7.49 billion in 2025 to approximately USD 11.46 billion by 2034, expanding at a CAGR of 4.83% from 2025 to 2034. The market is growing due to the rising demand for diagnostic imaging procedures, especially in oncology and cardiology.
The global drug repurposing market size accounted for USD 34.98 billion in 2024 and is predicted to increase from USD 36.87 billion in 2025 to approximately USD 59.30 billion by 2034, expanding at a CAGR of 5.42% from 2025 to 2034. The growth of the market is attributed to the rising demand for cost-effective strategy to accelerate drug development by finding new uses for existing drugs, reducing risk, and enhancing patient outcomes.
The global dental resin market size accounted for USD 4.07 billion in 2024 and is predicted to increase from USD 4.33 billion in 2025 to approximately USD 7.64 billion by 2034, expanding at a CAGR of 6.50% from 2025 to 2034. The market is experiencing substantial growth, driven by the rising adoption of aesthetic and durable restorative materials in dentistry, as well as the increasing demand for advanced dental treatments. Additionally, the growing preference for minimally invasive procedures and advancements in related technology are expected to boost market growth in the coming years.
The global aseptic connectors and welders market size accounted for USD 1.62 billion in 2024 and is predicted to increase from USD 1.86 billion in 2025 to approximately USD 6.57 billion by 2034, expanding at a CAGR of 15.03% from 2025 to 2034. The market is witnessing substantial growth because of the increasing emphasis on sterile and contamination-free manufacturing in the biopharmaceutical and pharmaceutical industries. Therefore, to address the growing adoption of single-use technologies and the rising demand for advanced solutions in vaccine and biologics production, this market shift toward automatic and efficient processes is projected to drive market expansion in the coming years.
The global phototherapy treatment market size accounted for USD 1.70 billion in 2024 and is predicted to increase from USD 1.77 billion in 2025 to approximately USD 2.58 billion by 2034, expanding at a CAGR of 4.25% from 2025 to 2034. The phototherapy treatment market is driven by the rising prevalence of chronic skin conditions, growing demand for non-invasive therapies, and advancements in light-based technology.
The global medical case management market size accounted for USD 5.73 billion in 2024 and is predicted to increase from USD 5.99 billion in 2025 to approximately USD 8.95 billion by 2034, expanding at a CAGR of 4.56% from 2025 to 2034. The demand for medical case management services has increased, driven by increased chronic disease prevalence, boosting the growth of the global medical case management market. Additionally, the rising need for personalized patient care is fostering the market growth.
The global dry chemistry analyzers market size accounted for USD 16.39 billion in 2024 and is predicted to increase from USD 17.61 billion in 2025 to approximately USD 33.62 billion by 2034, expanding at a CAGR of 7.45% from 2025 to 2034. The dry chemistry analyzers market is driven by demand for fast, accurate, and cost-effective diagnostic tools in healthcare, pharmaceuticals, and point-of-care testing.
The global patient lifting equipment market size accounted for USD 6.81 billion in 2024 and is predicted to increase from USD 7.12 billion in 2025 to approximately USD 10.61 billion by 2034, expanding at a CAGR of 4.53% from 2025 to 2034. The patient lifting equipment market is growing due to rising elderly and disabled populations, increasing demand for home healthcare, and a strong focus on reducing caregiver injuries.
The global veterinary API market size accounted for USD 5.35 billion in 2024 and is predicted to increase from USD 5.62 billion in 2025 to approximately USD 8.83 billion by 2034, expanding at a CAGR of 5.14% from 2025 to 2034. The veterinary API market is witnessing steady growth, driven by the rising focus on animal health, zoonotic disease control, and livestock productivity. With the increasing demand for high-quality animal-derived food products, veterinary pharmaceuticals have become essential in both companion and production animal healthcare.
The global peripheral arterial disease treatment market size accounted for USD 2.95 billion in 2024 and is predicted to increase from USD 3.17 billion in 2025 to approximately USD 6.11 billion by 2034, expanding at a CAGR of 7.56% from 2025 to 2034. The growth of the market is attributed to the rising disease prevalence, increased adoption of minimally invasive technologies, and ongoing innovation by leading medical device companies.
The global preventive healthcare technologies and services market size accounted for USD 300.58 billion in 2024 and is predicted to increase from USD 336.17 billion in 2025 to approximately USD 920.31 billion by 2034, expanding at a CAGR of 11.84% from 2025 to 2034. The market is witnessing substantial growth because of the advancements in screening tools, digital health platforms, and telemedicine solutions to address the growing need for early disease detection and prevention.
The global nasal irrigation market size accounted for USD 265.47 million in 2024 and is predicted to increase from USD 315.45 million in 2025 to approximately USD 1,494.40 million by 2034, expanding at a CAGR of 18.87% from 2025 to 2034. The nasal irrigation market is growing due to a growing awareness of sinus health, increasing prevalence of allergies and respiratory conditions, and a preference for non-invasive, at-home treatments with immediate and effective relief of symptoms.
The global pediatric healthcare market size accounted for USD 14.55 billion in 2024 and is predicted to increase from USD 15.77 billion in 2025 to approximately USD 32.48 billion by 2034, expanding at a CAGR of 6.52% from 2025 to 2034. The pediatric healthcare market is expanding due to rising childhood disease prevalence, increasing demand for specialized treatment, and advances in medical technology leading to strong growth along with access to quality care for children around the globe.
The global hemoglobin A1c testing devices market size accounted for USD 2.37 billion in 2024 and is predicted to increase from USD 2.52 billion in 2025 to approximately USD 4.46 billion by 2034, expanding at a CAGR of 6.52% from 2025 to 2034. The growth of the market is driven by the rising prevalence of diabetes, technological advancements in medical devices, and growing demand for cost-effective monitoring solutions.
The global robotic vial washing and filling machines market size accounted for USD 562.94 million in 2024 and is predicted to increase from USD 587.82 million in 2025 to approximately USD 867.56 million by 2034, expanding at a CAGR of 4.42% from 2025 to 2034. The market is witnessing rapid growth because of the increasing demand for automation in pharmaceutical manufacturing, driven by the rising production of injectable drugs, and the rising need for advanced aseptic processing technologies.
The global prosthetic disc nucleus market size was accounted for USD 135.24 million in 2024 and is predicted to increase from USD 145.69 million in 2025 to approximately USD 284.76 million by 2034, expanding at a CAGR of 7.73% from 2025 to 2034. The market is growing due to the increasing prevalence of degenerative disc diseases and the rising demand for minimally invasive spinal treatments.
The global phytoestrogen supplements market size accounted for USD 4.29 billion in 2024 and is predicted to increase from USD 4.50 billion in 2025 to approximately USD 6.82 billion by 2034, expanding at a CAGR of 4.73% from 2025 to 2034. The phytoestrogen supplements market is driven by rising demand for natural hormone alternatives to manage menopausal symptoms, support bone and heart health, and meet increasing consumer preference for plant-based wellness solutions.
The global physical therapy market size accounted for USD 24.27 billion in 2024 and is predicted to increase from USD 26.04 billion in 2025 to approximately USD 49.18 billion by 2034, expanding at a CAGR of 7.32% from 2025 to 2034. The growth of the market is attributed to the increasing awareness of musculoskeletal health, a growing geriatric population, and a rising demand for rehabilitation services following injury or surgery. As technology continues to integrate deeper into healthcare, innovations such as Artificial Intelligence (AI) are redefining traditional rehabilitation practices.
The global viral vectors for non-human primates market size accounted for USD 145.8 million in 2024 and is predicted to increase from USD 161.2 million in 2025 to approximately USD 397.87 million by 2034, expanding at a CAGR of 10.56% from 2025 to 2034. The increasing demand for novel gene therapies and the growing number of clinical studies are driving the growth of the market.
The global polio vaccine market size accounted for USD 1.14 billion in 2024 and is predicted to increase from USD 1.19 billion in 2025 to approximately USD 1.7 billion by 2034, expanding at a CAGR of 4.05% from 2025 to 2034. The growth of the polio vaccine market is driven by rising government initiatives, vaccination programs, health awareness campaigns, and global eradication initiatives.
The global microwave ablation devices market size accounted for USD 450.05 million in 2024 and is predicted to increase from USD 506.49 million in 2025 to approximately USD 1,466.66 million by 2034, expanding at a CAGR of 12.54% from 2025 to 2034. The increase in cancer cases, greater preference for minimally invasive procedures, and rapid advancements in technology that further improve precision and safety are driving the growth of the microwave ablation devices market.
The global low endotoxin gelatin market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.37 billion in 2025 to approximately USD 3.03 billion by 2034, expanding at a CAGR of 9.24% from 2025 to 2034. The growth of the market is attributed to the increasing demand for high-purity biomaterials in pharmaceutical and biomedical applications.
The global dysphagia management market size accounted for USD 4.71 billion in 2024 and is predicted to increase from USD 5.00 billion in 2025 to approximately USD 8.64 billion by 2034, expanding at a CAGR of 6.27% from 2025 to 2034. The growth of the market is attributed to the increasing prevalence of swallowing disorders among the aging population and patients with neurological conditions.
The global knee osteoarthritis (OA) injectable treatments market size accounted for USD 3.24 billion in 2024 and is predicted to increase from USD 3.46 billion in 2025 to approximately USD 6.37 billion by 2034, expanding at a CAGR of 7.00% from 2025 to 2034. The growing aging population, a rise in obesity (a risk factor for the development of knee osteoarthritis), and a preference for non-surgical pain management contribute to the growth of the market.
The global dental composites market size accounted for USD 3.74 billion in 2024 and is predicted to increase from USD 3.92 billion in 2025 to approximately USD 5.95 billion by 2034, expanding at a CAGR of 4.75% from 2025 to 2034. The market is experiencing significant growth due to the rising incidence of dental disorders and the increasing demand for aesthetic restorative materials. Advances in composite technologies provide enhanced durability and a natural tooth-like appearance. Additionally, the growing awareness of oral health and the increasing adoption of advanced dental procedures are expected to drive market growth.
The global pediatric electronic health records software market size accounted for USD 40.42 billion in 2024 and is predicted to increase from USD 43.39 billion in 2025 to approximately USD 82.15 billion by 2034, expanding at a CAGR of 7.35% from 2025 to 2034. The rapid shift of the healthcare industry toward digitalization is driving the global pediatric electronic health records software market. The increased number of medical records is driving demand for electronic health record software, contributing to the market growth.
The global peptide therapeutics contract API manufacturing market size accounted for USD 3.52 billion in 2024 and is predicted to increase from USD 3.84 billion in 2025 to approximately USD 8.36 billion by 2034, expanding at a CAGR of 9.04% from 2025 to 2034. The growth of the peptide therapeutics contract API manufacturing market is driven by the rising incidence of chronic diseases, increasing demand for personalized medicine, and improvements in peptide synthesis technologies.
The global immunoprotein diagnostic testing market size accounted for USD 9.58 billion in 2024 and is predicted to increase from USD 10.32 billion in 2025 to approximately USD 20.19 billion by 2034, expanding at a CAGR of 7.74% from 2025 to 2034. The market is expanding rapidly due to the rising prevalence of chronic and infectious diseases and technological advancements like ELISA. The rising demand for personalized medicine and improvements in healthcare infrastructure further support market growth.
The global human PBMC isolation kit market size accounted for USD 150.05 million in 2024 and is predicted to increase from USD 162.86 million in 2025 to approximately USD 340.51 million by 2034, expanding at a CAGR of 8.54% from 2025 to 2034. The growth of the human PBMC isolation kit market is driven by rising investments in research and development for creating innovative therapies, ongoing clinical trials, and the expansion of the biotech industry.
The global heart valve devices market size accounted for USD 13.34 billion in 2024 and is predicted to increase from USD 14.89 billion in 2025 to approximately USD 40.16 billion by 2034, expanding at a CAGR of 11.65% from 2025 to 2034. The growth of the market is driven by an increase in heart valve disease rates, growing elderly population, and high demand for minimally invasive procedures, providing safer, faster, and more effective treatments.
Discover trends, innovations, and forecasts shaping the global life science market, driving growth across biotechnology, pharma, and diagnostics. The market is experiencing rapid growth because of the increasing prevalence of chronic and infectious diseases and the growing demand for advanced diagnostic and therapeutic solutions. The market is further expanding due to significant advancements in biotechnology and genomic research. The growing emphasis on personalized medicines and the adoption of innovative technology are projected to drive market growth in the coming years.
The global PEEK interbody devices market size accounted for USD 2.41 billion in 2024 and is predicted to increase from USD 2.6 billion in 2025 to approximately USD 5.09 billion by 2034, expanding at a CAGR of 7.74% from 2025 to 2034. The PEEK interbody devices market is driven by increasing spinal disorders, an aging population, and the development of minimally invasive surgical technology.
The global oxycodone hydrochloride market size accounted for USD 4.36 billion in 2024 and is predicted to increase from USD 4.48 billion in 2025 to approximately USD 5.68 billion by 2034, expanding at a CAGR of 2.68% from 2025 to 2034. The rising demand for several pain relief solutions is driving the growth of the oxycodone hydrochloride market. Advancements in pharmaceutical formulations are advancing oxycodone hydrochloride drugs, contributing to the market expansion.
The global AI in sports market size accounted for USD 8.93 billion in 2024 and is predicted to increase from USD 10.82 billion in 2025 to approximately USD 60.78 billion by 2034, expanding at a CAGR of 21.14% from 2025 to 2034. The market growth is attributed to the rising integration of AI-driven analytics for injury prevention, tactical planning, and fan personalization across major sports leagues and training ecosystems.
The global lyophilization equipment and services market size accounted for USD 2.54 billion in 2024 and is predicted to increase from USD 2.73 billion in 2025 to approximately USD 5.26 billion by 2034, expanding at a CAGR of 7.55% from 2025 to 2034. The market is experiencing rapid growth due to ongoing advancements in lyophilization technology and high demand for lyophilized products.
The global pharmacy inventory management software solutions and cabinet market size accounted for USD 6.63 billion in 2024 and is predicted to increase from USD 7.15 billion in 2025 to approximately USD 14.23 billion by 2034, expanding at a CAGR of 7.94% from 2025 to 2034. The increasing demand for medications, rising volume of prescriptions, and regulatory compliance are driving the growth of this market.
The global neurosurgery market size accounted for USD 3.45 billion in 2024 and is predicted to increase from USD 3.6 billion in 2025 to approximately USD 5.33 billion by 2034, expanding at a CAGR of 4.45% from 2025 to 2034. The increasing incidence of neurological disorders, adoption of sophisticated surgical instruments, and demand for minimally invasive procedures are boosting the growth of the market.
Discover how the Malaysia plasma fractionation market is expanding with rising demand for immunoglobulins, albumin, and clotting factor therapies. The growth of the Malaysian plasma fractionation market is driven by the rising demand for plasma-derived therapies and strong government support.
The global alpha-1 antitrypsin deficiency augmentation therapy market size accounted for USD 1.63 billion in 2024 and is predicted to increase from USD 1.73 billion in 2025 to approximately USD 2.96 billion by 2034, expanding at a CAGR of 6.14% from 2025 to 2034. The growth of the alpha-1 antitrypsin deficiency augmentation therapy market is driven by rising awareness of genetic diseases, increasing diagnosis rates, technological advancements in protein therapies, and growing demand for targeted treatments for genetic respiratory disorders.
The global nebivolol tablets market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.32 billion in 2025 to approximately USD 2.09 billion by 2034, expanding at a CAGR of 5.25% from 2025 to 2034. The market is rapidly expanding due to the rising prevalence of hypertension and increasing healthcare expenditure. In addition, the growing aging population contributes to market expansion.
The global plasma therapeutics market size accounted for USD 26.65 billion in 2024 and is predicted to increase from USD 28.35 billion in 2025 to approximately USD 49.42 billion by 2034, expanding at a CAGR of 6.37% from 2025 to 2034. The plasma therapeutics market is growing at a rapid pace due to the rising demand for plasma-based therapies across the globe, advancements in technology, and increasing healthcare expenditure.
The global gender reassignment surgery market size accounted for USD 2.73 billion in 2024 and is predicted to increase from USD 2.93 billion in 2025 to approximately USD 5.51 billion by 2034, expanding at a CAGR of 7.27%% from 2025 to 2034. The gender reassignment surgery market is witnessing strong growth due to rising awareness of transgender identities, increasing government support, and growing demand for gender-affirming procedures.
The global pharmaceutical market size accounted for USD 1.67 trillion in 2024 and is predicted to increase from USD 1.77 trillion in 2025 to approximately USD 3.03 trillion by 2034, expanding at a CAGR of 6.15% from 2025 to 2034. The rising demand for vaccines, drugs, and personalized medicines is expected to boost the growth of the pharmaceutical market. The growing prevalence of chronic disease is fostering the demand for innovative drugs, contributing to market growth.
Israels FemTech industry is driven by digital health infrastructure, gender-specific innovation, and growing investment. Key areas include reproductive health, menopause, chronic care, and mental wellness.
The global radiation detection, monitoring and safety market size accounted for USD 1.68 billion in 2024 and is predicted to increase from USD 1.8 billion in 2025 to approximately USD 3.44 billion by 2034, expanding at a CAGR of 7.44% from 2025 to 2034. The market is expanding rapidly due to the increasing industrialization, the expansion of nuclear power plants, and rising applications in healthcare.
The global anti-D immunoglobulin market size accounted for USD 3.24 billion in 2024 and is predicted to increase from USD 3.42 billion in 2025 to approximately USD 5.55 billion by 2034, expanding at a CAGR of 5.53% from 2025 to 2034. The market is growing rapidly due to rising awareness of Rh incompatibility, government-supported immunization programs, and increasing demand for prophylactic treatment for hemolytic disease of the newborn.
The global women's health therapeutics market size accounted for USD 44.88 billion in 2024 and is predicted to increase from USD 46.69 billion in 2025 to approximately USD 66.62 billion by 2034, expanding at a CAGR of 4.03% from 2025 to 2034. The increasing awareness of women's health conditions and the common occurrence of conditions such as endometriosis, osteoporosis, and menopause-related ailments are driving the growth of the market. Moreover, the rising demand for customized treatments and governmental efforts to enhance women's healthcare access contribute to market growth.
The global life science logistics market size accounted for USD 17.69 billion in 2024 and is predicted to increase from USD 19.11 billion in 2025 to approximately USD 38.19 billion by 2034, expanding at a CAGR of 8.00% from 2025 to 2034. Growing demand for temperature-sensitive biologics, advances in cold chain technologies, increasing clinical trials globally, and growing investment in healthcare are driving the growth of the life science logistics market.
The global AI skin analysis market size accounted for USD 1.54 billion in 2024 and is predicted to increase from USD 1.79 billion in 2025 to approximately USD 7.11 billion by 2034, expanding at a CAGR of 16.53% from 2025 to 2034. The rising interest in customized skincare, developments in AI, high awareness of skin health, and integration of intelligent diagnostics in skincare are driving the growth of the AI skin analysis market.
The global non-alcoholic fatty liver disease (NAFLD) drug market size accounted for USD 20.97 billion in 2024 and is predicted to increase from USD 21.98 billion in 2025 to approximately USD 33.6 billion by 2034, expanding at a CAGR of 4.83% from 2025 to 2034. The market growth is attributed to the rising awareness of NAFLD and its complications, increasing demand for effective therapeutics, and the growing aging population.
The global hyperbaric oxygen therapy market size accounted for USD 3.76 billion in 2024 and is predicted to increase from USD 3.98 billion in 2025 to approximately USD 6.71 billion by 2034, expanding at a CAGR of 5.96% from 2025 to 2034. The growth of the hyperbaric oxygen therapy market is driven by rising incidences of chronic wounds, increasing awareness about advanced treatments, and the expanding scope of applications of hyperbaric oxygen therapy in neurological conditions.
The global muscle relaxant drugs market size accounted for USD 4.58 billion in 2024 and is predicted to increase from USD 4.80 billion in 2025 to approximately USD 7.31 billion by 2034, expanding at a CAGR of 4.78% from 2025 to 2034. The growth of the market is driven by the increasing aging population and the rising prevalence of musculoskeletal disorders.
The global synthetic small molecule API market size accounted for USD 186.52 billion in 2024 and is predicted to increase from USD 197.21 billion in 2025 to approximately USD 325.62 billion by 2034, expanding at a CAGR of 5.73% from 2025 to 2034. The increased chronic disease prevalence and demand for personalized medicines are fostering the growth of the synthetic small molecule API market. Additionally, the rising need for cost-effective generic drugs is driving the market growth.
The global mRNA therapeutics CDMO market size accounted for USD 4.57 billion in 2024 and is predicted to increase from USD 5.09 billion in 2025 to approximately USD 13.36 billion by 2034, expanding at a CAGR of 11.32% from 2025 to 2034. The growth of the market is driven by rising demand for personalized medicine, rapid vaccine development, advancements in mRNA technology.
The global live biotherapeutic products and microbiome CDMO market size accounted for USD 55.19 million in 2024 and is predicted to increase from USD 76.77 million in 2025 to approximately USD 1,496.69 million by 2034, expanding at a CAGR of 39.10% from 2025 to 2034. The growth of the live biotherapeutic product and microbiome market is driven by rising chronic disease prevalence. Advancements in microbiome research, increasing demand for personalized medicine, and growing investments in R&D further support market expansion.
The global healthcare data storage market size accounted for USD 5.49 billion in 2024 and is predicted to increase from USD 6.28 billion in 2025 to approximately USD 20.98 billion by 2034, expanding at a CAGR of 14.35% from 2025 to 2034. The growth of the market is driven by rising digitalization, increased patient data volumes, and rising adoption of cloud-based solutions.
The India healthcare cloud computing market size accounted for USD 3.03 billion in 2024 and is predicted to increase from USD 3.62 billion in 2025 to approximately USD 20.23 billion by 2034, expanding at a CAGR of 20.89% from 2025 to 2034. The growth of the market is attributed to the rising need for efficient data management and increasing use of telehealth and wearable technology.
The global sterile injectables CDMO market size accounted for USD 4.31 billion in 2024 and is predicted to increase from USD 4.73 billion in 2025 to approximately USD 10.91 billion by 2034, expanding at a CAGR of 9.73% from 2025 to 2034. The market is experiencing rapid growth due to the increasing demand for outsourcing services by pharmaceutical firms, stringent sterility requirements, and rising demand for injectable drugs.
The global veterinary point of care diagnostics market size accounted for USD 2.68 billion in 2024 and is predicted to increase from USD 2.96 billion in 2025 to approximately USD 7.23 billion by 2034, expanding at a CAGR of 10.44% from 2025 to 2034. The growth of the market is attributed to the increasing demand for rapid, on-site diagnostic solutions that enable early disease detection and timely treatment in animals.
The global livestock animal rehabilitation services market size accounted for USD 188.99 million in 2024 and is predicted to increase from USD 211.65 million in 2025 to approximately USD 586.45 million by 2034, expanding at a CAGR of 11.99% from 2025 to 2034. The growth of the market is driven by the rising awareness of animal welfare and progress in evidence-based treatments, veterinary diagnostics, and holistic rehabilitation techniques.
The global ketamine clinic market size accounted for USD 1.39 billion in 2024 and is predicted to increase from USD 1.52 billion in 2025 to approximately USD 3.35 billion by 2034, expanding at a CAGR of 9.20% from 2025 to 2034. With the increasing popularity and greater acceptance among physicians, the adoption of ketamine is expanding quickly to help those with mental health issues.
The global eHealth 2.0 market size accounted for USD 347.54 billion in 2024 and is predicted to increase from USD 381.36 billion in 2025 to approximately USD 879.55 billion by 2034, expanding at a CAGR of 9.73% from 2025 to 2034. The rising adoption of eICU, increasing need for remote patient monitoring, a surge in the number of telehealth clinics, and rapid technological innovation in healthcare technologies are expected to drive the growth of the global eHealth 2.0 market throughout the projected period.
The global investigational new drug CDMO market size accounted for USD 5.25 billion in 2024 and is predicted to increase from USD 5.61 billion in 2025 to approximately USD 10.26 billion by 2034, expanding at a CAGR of 6.93% from 2025 to 2034. The growth of the market is driven by rising clinical trials, increasing demand for outsourcing services, and high demand for biologics.
The global skin substitute market size accounted for USD 386.83 million in 2024 and is predicted to increase from USD 419.56 million in 2025 to approximately USD 871.4 million by 2034, expanding at a CAGR of 8.46% from 2025 to 2034. The market is experiencing rapid growth because of the rising demand for effective wound healing and tissue regeneration in various medical contexts, particularly for chronic wounds and burn injuries.
The global veterinary oncology market size accounted for USD 1.62 billion in 2024 and is predicted to increase from USD 1.82 billion in 2025 to approximately USD 5.09 billion by 2034, expanding at a CAGR of 12.14% from 2025 to 2034. The growth of the market is driven by rising incidence of pets with cancer and improving diagnostic and treatment approaches.
The global transcranial magnetic stimulation system market size accounted for USD 1.38 billion in 2024 and is predicted to increase from USD 1.51 billion in 2025 to approximately USD 3.33 billion by 2034, expanding at a CAGR of 9.22% from 2025 to 2034. The growth of the market is attributed to the rising prevalence of depression and neurological disorders, along with increasing demand for non-invasive and drug-free treatment options.
The global integrated delivery network market size accounted for USD 12.09 billion in 2024 and is predicted to increase from USD 13.41 billion in 2025 to approximately USD 34.05 billion by 2034, expanding at a CAGR of 10.91% from 2025 to 2034. The growth of the market is driven by the rising need for a comprehensive range of healthcare services and value-based care.
The global anomaly detection market size accounted for USD 5.91 billion in 2024 and is predicted to increase from USD 6.90 billion in 2025 to approximately USD 28.00 billion by 2034, expanding at a CAGR of 16.83% from 2025 to 2034. The increased demand for predictive analytics solutions in various industries is driving the global anomaly detection market. Increased incidence of cyber threats and innovations and advancements in anomaly detection tools contribute to market growth.
The global veterinary diagnostics market size accounted for USD 10.75 billion in 2024 and is predicted to increase from USD 11.83 billion in 2025 to approximately USD 28.06 billion by 2034, expanding at a CAGR of 10.07% from 2025 to 2034. The veterinary diagnostics market is witnessing robust growth, driven by rising pet ownership, increased awareness of animal health, and advancements in diagnostic technologies.
Radionuclide Injection Market is growing with rising demand in diagnostics and therapy. Explore regional trends, innovations, and competitive analysis, expanding at a CAGR of 10.04% from 2025 to 2034. The demand for diagnostic procedures like positron emission tomography (PET) scans has increased, driving the growth of the market for radionuclide injection. Advancements in nuclear medicine are expected to drive innovations in radionuclide injections, fostering market growth.
Uncover the future of the neuropsychiatry market, from cutting-edge treatments to market dynamics, global expansion, and competitive landscape insights. The neuropsychiatry market is growing due to rising mental health awareness, increasing prevalence of neurological disorders, growing geriatric population, and advancements in diagnostic technologies.
The global leadless pacemakers market size was calculated at USD 711.37 million in 2024 and is predicted to increase from USD 748.36 million in 2025 to approximately USD 1181.01 million by 2034, expanding at a CAGR of 13.74% from 2025 to 2034. The increased prevalence of cardiac conditions and aging populations are the major factors driving the growth of the leadless pacemakers market. Government investments and private insurance coverage are driving adoptions of leadless pacemakers.
The global deferiprone market size was calculated at USD 40.12 million in 2024 and is predicted to increase from USD 41.56 million in 2025 to approximately USD 57.14 million by 2034, expanding at a CAGR of 3.60% from 2025 to 2034. The market growth is attributed to the increasing prevalence of iron overload disorders, advancements in therapeutics, and growing awareness about the importance of early diagnosis and management.
The global trauma care centers market size accounted for USD 17.42 billion in 2024 and is predicted to increase from USD 18.74 billion in 2025 to approximately USD 36.24 billion by 2034, expanding at a CAGR of 7.60% from 2025 to 2034. The growth of the market is attributed to the increasing incidence of road accidents, natural disasters, and violence-related injuries, requiring immediate and specialized medical attention.
The global amniocentesis needle market size accounted for USD 210.37 million in 2024 and is predicted to increase from USD 225.31 million in 2025 to approximately USD 417.71 million by 2034, expanding at a CAGR of 7.10% from 2025 to 2034. The market growth is attributed to the increasing prevalence of high-risk pregnancies and advancements in prenatal genetic testing technologies.
The global neutralizing antibody market size accounted for USD 232.04 billion in 2024 and is predicted to increase from USD 252.23 billion in 2025 to approximately USD 534.39 billion by 2034, expanding at a CAGR of 8.70% from 2025 to 2034. The market growth is attributed to the increasing prevalence of infectious diseases. Advancements in monoclonal and polyclonal antibody development techniques and rising demand for personalized therapies further drive the market’s growth.
The global endoscopy and ambulatory surgical center market size was calculated at USD 644.63 billion in 2024 and is predicted to increase from USD 666.55 billion in 2025 to approximately USD 893.70 billion by 2034, expanding at a CAGR of 3.32% from 2025 to 2034. The growth of the market is attributed to the rising demand for minimally invasive procedures that offer faster recovery and reduce hospital stays.
The global medicated skincare market size accounted for USD 45.90 billion in 2024 and is predicted to increase from USD 48.38 billion in 2025 to approximately USD 77.66 billion by 2034, expanding at a CAGR of 5.40% from 2025 to 2034. The growth of the market is driven by the rising demand for clinically proven products to manage and treat skin conditions.
The global veterinary biomarkers market size was calculated at USD 1.10 billion in 2024 and is predicted to increase from USD 1.24 billion in 2025 to approximately USD 3.73 billion by 2034, expanding at a CAGR of 13.00% from 2025 to 2034. The market is growing at a rapid pace due to the increasing demand for rapid and accurate disease diagnosis in animals. Advancements in biotechnology and rising awareness of pet health and wellness further support market growth.
The global senolytics and anti-aging pharmaceuticals market size was estimated at USD 4.18 billion in 2024 and is predicted to increase from USD 4.50 billion in 2025 to approximately USD 8.72 billion by 2034, expanding at a CAGR of 7.63% from 2025 to 2034. The growth of the market is driven by the rising research activities aimed at understanding aging and senescence. Furthermore, the rising demand for solutions to avoid the degenerative processes of aging and associated chronic diseases drives the growth of the market.
The global pet herbal supplements market size was estimated at USD 1.07 billion in 2024 and is predicted to increase from USD 1.18 billion in 2025 to approximately USD 2.96 billion by 2034, expanding at a CAGR of 10.71% from 2025 to 2034. The growth of the market is driven by increasing awareness among pet owners about natural and holistic health solutions for their pets.
The global herceptin market size accounted for USD 3.26 billion in 2024 and is predicted to increase from USD 3.44 billion in 2025 to approximately USD 5.61 billion by 2034, expanding at a CAGR of 5.58% from 2025 to 2034. The market growth is driven by the growing number of HER2-positive cancer patients, rising acceptance of precision medicine, and expanding global healthcare systems.
The global federated learning in healthcare market size accounted for USD 30.62 million in 2024 and is predicted to increase from USD 35.67 million in 2025 to approximately USD 141.01 million by 2034, expanding at a CAGR of 16.50% from 2025 to 2034. The market is witnessing significant growth due to the rising concerns about data privacy and security in the healthcare sector. The increasing adoption of AI-based models to transform the delivery of healthcare services by improving diagnosis, treatment, and research further supports market growth.
The global anti-aging supplements market size accounted for USD 4.52 billion in 2024 and is predicted to increase from USD 4.88 billion in 2025 to approximately USD 9.79 billion by 2034, expanding at a CAGR of 8.03% from 2025 to 2034. The aging population and the rapid shift toward natural wellness practices drive the growth of the market.
The U.S. multiple sclerosis drugs market size accounted for USD 7.81 billion in 2024 and is predicted to increase from USD 8.44 billion in 2025 to approximately USD 17.15 billion by 2034, expanding at a CAGR of 8.18% from 2025 to 2034. The growth of the U.S. multiple sclerosis drugs market is driven by the increased prevalence and awareness of multiple sclerosis, the availability of better diagnostic tools, and the rising regulatory approvals for innovative therapies.
The global multiple sclerosis drugs market size accounted for USD 21.26 billion in 2024 and is predicted to increase from USD 22.96 billion in 2025 to approximately USD 45.90 billion by 2034, expanding at a CAGR of 8.00% from 2025 to 2034. The growth of the market is driven by ongoing clinical trials, increasing approvals from regulatory agencies, and rising investments in R&D activities for developing new therapies.
The global measles, mumps, rubella vaccine market size accounted for USD 1.86 billion in 2024 and is predicted to increase from USD 2.02 billion in 2025 to approximately USD 4.21 billion by 2034, expanding at a CAGR of 8.51% from 2025 to 2034. The rising efforts of public health agencies to increase the awareness about benefits of vaccination in communities across the world is likely to boost the growth of the market during the forecast period.
The global aminoglycosides market size was estimated at USD 7.1 billion in 2024 and is predicted to increase from USD 7.55 billion in 2025 to approximately USD 13.1 billion by 2034, expanding at a CAGR of 6.32% from 2025 to 2034. The growth of the market is driven by the increasing government funding in research and development activities aimed at infectious and bacterial diseases.
The global pancreatic cancer precision medicine market size accounted for USD 690.11 billion in 2024 and is predicted to increase from USD 823.30 million in 2025 to approximately USD 4,030.16 million by 2034, expanding at a CAGR of 19.30% from 2025 to 2034. The growing adoption of targeted therapies is the key factor driving the growth of the market. Also, the increasing shift towards precision medicine, coupled with the ongoing integration of bioinformatics and next-generation sequencing technologies, can fuel market growth further.
The immune monitoring solutions market is expected to grow at a CAGR of 13.00% from 2025 to 2034, driven by rising demand for precision immunology and diagnostics. The market is expanding due to the rising prevalence of diseases, immunotherapy advancements, and personalized medicine demand, driven by high-throughput sequencing, flow cytometry, and multiplex assays.
The oncology proteomics advances cancer research and precision medicine through biomarker discovery, protein analysis, and targeted therapies for improved patient outcomes. The growth of the market is driven by the rising burden of cancer worldwide and the increasing demand for personalized medicine.
The global colorado legal cannabis market size accounted for USD 2.65 billion in 2024 and is predicted to increase from USD 2.99 billion in 2025 to approximately USD 9.00 billion by 2034, expanding at a CAGR of 13.00% from 2025 to 2034. The growth of the market is driven by increased acceptance of cannabis in the medical field.
The global small molecule innovator CDMO market size was calculated at USD 53.07 billion in 2024 and is predicted to increase from USD 56.41 billion in 2025 to approximately USD 97.67 billion by 2034, expanding at a CAGR of 6.29% from 2025 to 2034. Increasing R&D investments are fuelling growth in the market, as pharmaceutical companies seek specialized partners for advanced development, regulatory compliance, and efficient manufacturing solutions.
The global dental implantology software market size accounted for USD 230.41 million in 2024 and is predicted to increase from USD 243.08 million in 2025 to approximately USD 393.57 million by 2034, expanding at a CAGR of 5.50% from 2025 to 2034. The excellent features driven by dental implantology software with accuracy, precision, and efficiency in clinical performance, ensuring promising surgical outcomes.
The global tissue dissociation market size was calculated at USD 326.11 million in 2024 and is predicted to increase from USD 354.16 million in 2025 to approximately USD 744.15 million by 2034, expanding at a CAGR of 8.60% from 2025 to 2034. The growth of the market is driven by the increasing government funding for cell-based research. The rising demand for personalized treatments further supports market expansion.
The global menstrual cup market size was estimated at USD 865.04 million in 2024 and is predicted to increase from USD 913.83 million in 2025 to approximately USD 1,497.34 million by 2034, expanding at a CAGR of 5.64% from 2025 to 2034. The growth of the market is attributed to the rising demand for sustainable feminine hygiene products, increased health consciousness, and growing acceptance of reusable menstrual care products.
The oral iron supplements market is growing as demand rises due to higher anemia rates, increased health consciousness, and broader healthcare accessibility. The market growth is attributed to the increased demand for safe, effective, and easily absorbable iron formulations across diverse age groups for treating health conditions like IDA.
India Class C and Class D medical devices market size accounted for USD 6.40 billion in 2024 and is predicted to increase from USD 6.82 billion in 2025 to approximately USD 12.57 billion by 2034, expanding at a CAGR of 7.00% from 2025 to 2034. The market shows rapid growth because of increased healthcare investment, government endorsement, heightened chronic illness statistics, and technological progress, which leads to the use of advanced medical products.
The global oral antibiotics market size accounted for USD 23.8 billion in 2024 and is predicted to increase from USD 24.43 billion in 2025 to approximately USD 30.89 billion by 2034, expanding at a CAGR of 2.64% from 2025 to 2034. The market is driven by rising bacterial infections, antibiotic resistance concerns, pharmaceutical innovations, and expanding healthcare access, fueling demand for advanced, effective, and accessible treatments worldwide.
The global over the counter (OTC) test market size accounted for USD 22.23 billion in 2024 and is predicted to increase from USD 24.69 billion in 2025 to approximately USD 63.35 billion by 2034, expanding at a CAGR of 11.04% from 2025 to 2034. The increasing need for rapid and effective testing solutions across the world is expected to boost the growth of the market during the forecast period.
The U.S. intra-abdominal pressure measurement devices market size accounted for USD 65.83 billion in 2024 and is predicted to increase from USD 71.26 billion in 2025 to approximately USD 147.57 billion by 2034, expanding at a CAGR of 8.41% from 2025 to 2034. The market growth is driven by the rising number of trauma incidences, ongoing advancements in medical device technologies and growing number of abdominal procedures in the U.S.
The global laboratory products and outsourcing services market size accounted for USD 38.6 billion in 2024 and is predicted to increase from USD 41.78 billion in 2025 to approximately USD 85.28 billion by 2034, expanding at a CAGR of 8.25% from 2025 to 2034. The rising occurrence of intricate diseases and the need for improved diagnostics are fueling expansion in the market. The increasing use of personalized medicine, non-invasive technologies, and outsourcing for cost-effectiveness and regulatory adherence also drives market growth.
The global monocyte activation test market size was accounted for USD 593.45 million in 2024 and is predicted to increase from USD 687.99 million in 2025 to approximately USD 2,602.21 million by 2034, expanding at a CAGR of 15.93% from 2025 to 2034. Growing awareness regarding ethical testing methods is the key factor driving market growth. Also, innovations in monocyte activation test (MAT) technology, coupled with the collaborations between market players, can fuel market growth soon.
The global apheresis equipment market size accounted for USD 3.21 billion in 2024 and is predicted to increase from USD 3.51 billion in 2025 to approximately USD 7.77 billion by 2034, expanding at a CAGR of 9.24% from 2025 to 2034. The increasing incidence of blood-related disorders is the key factor driving market growth. Also, technological advancements in apheresis devices coupled with the growing demand for blood components can fuel market growth further.
The global intra-abdominal pressure measurement devices market size accounted for USD 156.74 million in 2024 and is predicted to increase from USD 169.66 million in 2025 to approximately USD 345.99 million by 2034, expanding at a CAGR of 8.24% from 2025 to 2034. The market growth can be linked to the rising intra-abdominal incidences, ongoing research activities and growing demand for non-invasive procedures.
The global next-generation IVD market size accounted for USD 9.18 billion in 2024 and is predicted to increase from USD 9.69 billion in 2025 to approximately USD 15.61 billion by 2034, expanding at a CAGR of 5.45% from 2025 to 2034. Ongoing technological advancements, innovations in genomics, proteomics, and molecular diagnostics, and rising development of personalized and precision medical are driving the growth of the market.
The global genetic engineering market size was calculated at USD 1.62 billion in 2024 and is predicted to increase from USD 1.72 billion in 2025 to approximately USD 2.94 billion by 2034, expanding at a CAGR of 6.15% from 2025 to 2034. The growth of the market is driven by increasing government grants and funding to biotech startups. The rising production of vaccines and biologics further contributes to market growth.
The global dermatology excimer laser market size was estimated at USD 644.98 million in 2024 and is predicted to increase from USD 711.67 million in 2025 to approximately USD 1,725.35 million by 2034, expanding at a CAGR of 10.34% from 2025 to 2034. The growth of the dermatology excimer laser market is driven by the rising prevalence of skin diseases and high demand for cosmetic procedures.
The U.S. dental software market size was calculated at USD 490 million in 2024 and is predicted to increase from USD 540 million in 2025 to approximately USD 1,210 million by 2034, expanding at a CAGR of 9.46% from 2025 to 2034. Growing due increasing adoption of digital solutions for efficient practice management and improved patient care.
The global X-ray inspection system market size accounted for USD 2.55 billion in 2024 and is predicted to increase from USD 2.70 billion in 2025 to approximately USD 4.46 billion by 2034, expanding at a CAGR of 5.74% from 2025 to 2034. The market is predominantly fueled by growing security concerns, prompting airports, transportation hubs, and critical infrastructure facilities to make substantial investments in advanced X-ray technologies aimed at strengthening them.
The global leukapheresis devices market size accounted for USD 32.54 billion in 2024 and is predicted to increase from USD 35.12 billion in 2025 to approximately USD 70.01 billion by 2034, expanding at a CAGR of 7.97% from 2025 to 2034. The growing prevalence of leukemia is the key factor driving market growth. Also, technological innovations in leukapheresis procedures, coupled with the rising demand for personalized medicine, can fuel market growth further.
The global lithotripsy devices market size was calculated at USD 1.4 billion in 2024 and is predicted to increase from USD 1.5 billion in 2025 to approximately USD 2.62 billion by 2034, expanding at a CAGR of 6.44% from 2025 to 2034. The lithotripsy devices market is expected to grow at a rapid pace due to the rising government initiatives to boost the domestic production of medical devices.
The global live attenuated vaccines market size was estimated at USD 28.97 billion in 2024 and is predicted to increase from USD 32.17 billion in 2025 to approximately USD 82.63 billion by 2034, expanding at a CAGR of 11.05% from 2025 to 2034. The demand for market is increasing because of the surge in infectious diseases, worldwide vaccination initiatives and a transition to preventive healthcare. The market is anticipated to grow with an emphasis on non-invasive techniques such as intranasal vaccines.
The global rare cell isolation market size accounted for USD 2.05 billion in 2024 and is predicted to increase from USD 2.25 billion in 2025 to approximately USD 5.2 billion by 2034, expanding at a CAGR of 9.75% from 2025 to 2034. rising demand for precision medicine is expected to boost the growth of the market during the forecast period.
The global immunology biosimilars market size was calculated at USD 9.52 billion in 2024 and is predicted to increase from USD 11.23 billion in 2025 to approximately USD 49.61 billion by 2034, expanding at a CAGR of 17.95% from 2025 to 2034. The market is experiencing growth due to the increasing prevalence of chronic immunological diseases requiring immunotherapies, the increasing demand for cost-effective treatments, and the need for more accessible therapies by propelling the demand for immunology biosimilars.
The global peripheral blood mononuclear cells market size was calculated at USD 287.4 billion in 2024 and is predicted to increase from USD 317.35 billion in 2025 to approximately USD 774.41 billion by 2034, expanding at a CAGR of 10.42% from 2025 to 2034. The growth of the peripheral blood mononuclear cells market is attributed to the ongoing research activities for regenerative medicine and the rising development of immunotherapies. The rising demand for cell and gene therapies and a strong emphasis on the utilization of non-animal methods (NAMs) for material safety to expand next-generation risk assessment approaches (NGRA) support market growth.
The global xenotransplantation market size was estimated at USD 2.84 billion in 2024 and is predicted to increase from USD 3.12 billion in 2025 to approximately USD 7.26 billion by 2034, expanding at a CAGR of 9.84% from 2025 to 2034. An increase in cases of kidney and heart diseases around the world is expected to fuel the growth of the market during the forecast period.
The global perfusion systems market size accounted for USD 5.06 billion in 2024 and is predicted to increase from USD 5.64 billion in 2025 to approximately USD 15.03 billion by 2034, expanding at a CAGR of 11.50% from 2025 to 2034. Worldwide health infrastructure improvements, rising transplant volumes, increasing cardiovascular diseases, and research in pharmaceutical medicine sustain the consistent development of the market.
The global alkaptonuria therapeutics market size accounted for USD 15.10 million in 2024 and is predicted to increase from USD 16.19 million in 2025 to approximately USD 30.32 million by 2034, expanding at a CAGR of 7.22% from 2025 to 2034. The market growth is attributed to increasing research efforts, rising adoption of targeted therapies, and expanding rare disease awareness programs, driving early diagnosis and improved treatment accessibility.
The global dental matrix systems market size accounted for USD 420.16 million in 2024 and is predicted to increase from USD 445.37 million in 2025 to approximately USD 752.44 million by 2034, expanding at a CAGR of 6% from 2025 to 2034. The emerging need of people to recreate natural teeth and protect adjacent teeth by improving restoration longevity is expected to boost the growth of the dental matrix systems market during the forecast period.
The global refurbished dental equipment market size accounted for USD 1.05 billion in 2024 and is predicted to increase from USD 1.13 billion in 2025 to approximately USD 2.19 billion by 2034, expanding at a CAGR of 7.60% from 2025 to 2034. Refurbished dental equipment offers a cost-effective, eco-friendly solution for growing dental clinics. With rising dental visits and better quality checks, demand is increasing, making it a preferred choice for many professionals.
The global normothermic machine perfusion market size accounted for USD 1.71 billion in 2024 and is predicted to increase from USD 2.02 billion in 2025 to approximately USD 9.03 billion by 2034, expanding at a CAGR of 18.10% from 2025 to 2034. The market is driven by rising organ needs, technological advances with regulatory support. Furthermore, the growing understanding of NMP benefits is driving transplant clinics to become important success enhancers while prompting them to implement this technology more frequently.
The global prophy dental handpiece market size accounted for USD 244.12 million in 2024 and is predicted to increase from USD 258.28 million in 2025 to approximately USD 429 million by 2034, expanding at a CAGR of 5.80% from 2025 to 2034. The prophy dental handpiece market is growing due to increasing demand for preventive dental care. Furthermore, technological advancements and growing dental tourism contribute to market growth.
The global natural killer (NK) cell therapeutics market size was estimated at USD 340.25 million in 2024 and is predicted to increase from USD 477.10 million in 2025 to approximately USD 9,997.65 million by 2034, expanding at a CAGR of 40.22% from 2025 to 2034. The growth of the natural killer (NK) cell therapeutics market is driven by the rising mergers and acquisitions among biopharmaceutical companies, the potential for addressing unmet medical needs, and increased adoption and installation of advanced diagnostic platforms in various healthcare settings.
The global leukapheresis market size accounted for USD 219.47 million in 2024 and is predicted to increase from USD 243.83 million in 2025 to approximately USD 628.80 billion by 2034, expanding at a CAGR of 11.10% from 2025 to 2034. The rising incidence of blood disorders across the globe is the key factor driving the growth of the market. Also, technological innovations in leukapheresis procedures, coupled with the increasing need for personalized medicine, can fuel market growth further.
The global medical device clinical trials market size was calculated at USD 16.70 billion in 2024 and is predicted to increase from USD 17.74 billion in 2025 to approximately USD 30.53 billion by 2034, expanding at a CAGR of 6.22% from 2025 to 2034. The demand for medical device clinical trials is increasing due to the rising prevalence of chronic disease, which is driving advancements in the healthcare industry.
The global nitinol-based medical device market size was estimated at USD 4.66 billion in 2024 and is predicted to increase from USD 5.00 billion in 2025 to approximately USD 9.37 billion by 2034, expanding at a CAGR of 7.23% from 2025 to 2034. The market growth is driven by rising production of medical devices, ongoing technological advancements, and increasing healthcare expenditures.
The global medical device services market size was calculated at USD 17.77 billion in 2024 and is predicted to increase from USD 19.11 billion in 2025 to approximately USD 36.76 billion by 2034, expanding at a CAGR of 7.54% from 2025 to 2034. The market shows rapid growth due to technological progress and a customer need for advanced healthcare solutions of high quality.
The global medical metal tubing market size accounted for USD 756.46 million in 2024 and is predicted to increase from USD 812.59 million in 2025 to approximately USD 1,547.53 million by 2034, expanding at a CAGR of 7.42% from 2025 to 2034. The medical metal tubing market is growing rapidly due to the increasing government funding to improve healthcare infrastructure and the rising demand for medical devices.
The diabetes management technologies market is set to grow by 2034, driven by advancements in glucose monitoring, insulin delivery, and digital health solutions for better patient outcomes. The demand for self-management solutions has increased, driving the growth of the market. Technological advancements and digitalization are further fueling the adoption of management technologies. Additionally, the demand for personalized solutions boosts market expansion.
The global sarcoidosis drug market size accounted for USD 8.31 billion in 2024 and is predicted to increase from USD 8.82 billion in 2025 to approximately USD 15.09 billion by 2034, expanding at a CAGR of 6.15% from 2025 to 2034. The market is growing because of the rising prevalence of sarcoidosis, necessitating prompt diagnosis and efficient therapies. Focused therapies, non-invasive diagnostic methods, and innovative drugs are driving market expansion, enhancing patient outcomes, and reducing the use of corticosteroids.
The global medical 3D printing plastics market size accounted for USD 682.04 Million in 2024 and is predicted to increase from USD 853.91 million in 2025 to approximately USD 6,454.36 million by 2034, expanding at a CAGR of 25.20% from 2025 to 2034. The market growth is attributed to the increasing demand for personalized healthcare solutions and the advancements in 3D printing technologies that enable the production of custom medical devices and implants.
The global bovine artificial insemination market size accounted for USD 3.21 billion in 2024 and is predicted to increase from USD 3.42 billion in 2025 to approximately USD 5.97 billion by 2034, expanding at a CAGR of 6.41% from 2025 to 2034. The market is growing due to the increasing demand for genetic improvement, enhanced reproductive efficiency, and advancements in breeding technologies.
The global glaucoma drainage devices market size was estimated at USD 1.33 billion in 2024 and is predicted to increase from USD 1.45 billion in 2025 to approximately USD 3.12 billion by 2034, expanding at a CAGR of 8.90% from 2025 to 2034. The glaucoma drainage devices market is growing rapidly due to rising government initiatives to spread awareness about early detection to prevent blindness, advancements in drainage devices, and the growing prevalence of glaucoma.
The global elastomeric infusion pumps market size accounted for USD 692.10 million in 2024 and is predicted to increase from USD 742.21 million in 2025 to approximately USD 1,392.31 million by 2034, expanding at a CAGR of 7.24% from 2025 to 2034. The surging prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders is a key factor driving the growth of the market. Also, the increasing demand for home healthcare solutions, coupled with the innovations in pump design and user interfaces, can fuel market growth soon.
Medical lab technology drives modern healthcare enabling accurate diagnosis, treatment, and disease monitoring with advanced tools and precise testing. The growth of the market is driven by increasing government support to improve healthcare and research facilities. Moreover, the expansion of healthcare infrastructure in rural areas supports market growth.
The Australia GLP-1 receptor agonist market size accounted for USD 499.12 million in 2024 and is predicted to increase from USD 570.49 million in 2025 to approximately USD 1,899.62 million by 2034, expanding at a CAGR of 14.30% from 2025 to 2034. The growth of the Australia GLP-1 receptor agonist market is driven by the rising demand for effective medications, the need for management of diabetes and obesity, ongoing clinical trials and increased research on developing long-term single-dose formulations.
The global pet DNA testing market size accounted for USD 406.11 million in 2024 and is predicted to increase from USD 447.94 million in 2025 to approximately USD 1,082.43 million by 2034, expanding at a CAGR of 10.30% from 2025 to 2034. This market is growing due to increasing pet ownership and rising interest in genetic health.
The global perfusion disposables market size accounted for USD 2.87 billion in 2024 and is predicted to increase from USD 3.11 billion in 2025 to approximately USD 6.37 billion by 2034, expanding at a CAGR of 8.30% from 2025 to 2034. The prefusion disposal market is witnessing significant growth due to the increasing demand for advanced medical research tools in drug development, organ transplantation, and regenerative medicine. These disposable components, including tubing sets, oxygenators, and reservoirs, play a crucial role in maintaining sterile and efficient and perfusion systems.
The global in-line UV-vis spectroscopy market size accounted for USD 1.29 billion in 2024 and is predicted to increase from USD 1.38 billion in 2025 to approximately USD 2.47 billion by 2034, expanding at a CAGR of 6.72% from 2025 to 2034. The market is increasing due to growing concerns about environmental issues that need to be addressed, as well as the need to meet safety regulations in the food and beverage industry, along with monitoring and testing processes in several industries, driving the market further on a global scale.
The global hospital equipment and supplies market size was estimated at USD 44.03 billion in 2024 and is predicted to increase from USD 49.42 billion in 2025 to approximately USD 139.83 billion by 2034, expanding at a CAGR of 12.25% from 2025 to 2034. The increasing prevalence of chronic diseases worldwide, rising healthcare expenditure, rising emphasis on measures to control hospital-acquired infections (HAIs), and technological innovations in hospital equipment are among several factors expected to drive the growth of the hospital equipment and supplies market throughout the projection period.
The global leukemia inhibitory factor (LIF) market size accounted for USD 1.23 billion in 2024 and is predicted to increase from USD 1.34 billion in 2025 to approximately USD 2.90 billion by 2034, expanding at a CAGR of 8.94% from 2025 to 2034. With the rising investments in cancer research and the development of novel cancer treatments, the leukemia inhibitory factor (LIF) market is experiencing exceptional growth globally.
The global intravenous infusion pump market size accounted for USD 6.21 billion in 2024 and is predicted to increase from USD 6.72 billion in 2025 to approximately USD 13.80 billion by 2034, expanding at a CAGR of 7.03% from 2025 to 2034. The growth of the market is driven by the increase of chronic diseases, growing healthcare spending, and an aging population. The increase in surgical procedures and the movement to home healthcare is driving demand for more advanced and portable infusion pumps.
The global surgical sponge market size accounted for USD 2.50 billion in 2024 and is predicted to increase from USD 2.64 billion in 2025 to approximately USD 4.41 billion by 2034, expanding at a CAGR of 5.84% from 2025 to 2034. This growth is due to the increasing number of surgeries and advancements in healthcare infrastructure.
The global medical supplies and labware market size was estimated at USD 204 billion in 2024 and is predicted to increase from USD 212.09 billion in 2025 to approximately USD 318.30 billion by 2034, expanding at a CAGR of 4.61% from 2025 to 2034. The ongoing innovative product launches, growing demand for automated and streamlined workflow platforms, and expanding healthcare infrastructure are the factors fostering the growth of the market.
The global bladder cancer therapeutics diagnostics market size accounted for USD 5.36 billion in 2024 and is predicted to increase from USD 5.68 billion in 2025 to approximately USD 9.53 billion by 2034, expanding at a CAGR of 5.92% from 2025 to 2034. The market is witnessing considerable expansion owing to the increasing prevalence and awareness of bladder cancer. Progress in precision medicine and tailored treatment methods, coupled with non-invasive diagnostic tools, is fostering this growth.
